ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NXL Nexalin Technologies Inc

1.44
0.055 (3.97%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Nexalin Technologies Inc NXL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.055 3.97% 1.44 23:00:08
Open Price Low Price High Price Close Price Previous Close
1.45 1.41 1.54 1.44 1.385
more quote information »

Recent News

Date Time Source Heading
4/25/202409:44GLOBENexalin Technology Regains Compliance with Nasdaq Continued..
4/09/202407:30GLOBENexalin Technology Accelerates Manufacturing of its HALO™..
4/04/202412:00GLOBENexalin Technology Awarded Key Patent Related to its Gen-3..
4/02/202407:30GLOBENexalin Technology Announces the Appointment of Government..
3/28/202407:30GLOBENexalin Technology Announces Positive Results of Clinical..
3/14/202407:30GLOBENexalin Technology Commences Sales of Gen-2 Neurostimulation..
3/13/202407:30GLOBENexalin Technology Announces Poster Presentation at “State..
2/08/202407:30GLOBENexalin Technology Announces Regulatory Approval in Oman for..
1/23/202407:30GLOBENexalin Technology Awarded Key Patent Related to its..
1/11/202407:30GLOBENexalin Technology Unveils Next-Generation HALO™ Clarity
12/18/202307:30GLOBENexalin Technology Reports Significant Positive Results of..
11/13/202315:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202313:38EDGAR2Form 8-K - Current report
10/25/202307:30GLOBENexalin Technology Announces Formation of New Military &..
10/16/202307:30GLOBENexalin Technology Announces Publication of Groundbreaking..
10/05/202311:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202311:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202311:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/28/202315:18EDGAR2Form 8-K - Current report
8/10/202314:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202307:30GLOBENexalin Technology Reports Results of Clinical Study..
8/03/202307:30GLOBENexalin’s CEO Mark White to be Interviewed Live on “The Big..
7/26/202307:30GLOBENexalin Technology Announces New Public Sector Division to..
7/10/202307:30GLOBENexalin Technology Announces Abstract Accepted for..
6/30/202314:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
6/01/202307:30GLOBENexalin Technology, Inc. and Wider Come Limited Announce..

Your Recent History

Delayed Upgrade Clock